US Stock MarketDetailed Quotes
TRIB Trinity Biotech
- 3.2900
- +0.5300+19.20%
Close Jul 12 16:00 ET
- 3.3000
- +0.0100+0.30%
Post 19:10 ET
31.14MMarket Cap-1195P/E (TTM)
3.3000High2.5400Low96.65KVolume2.7100Open2.7600Pre Close286.46KTurnover2.02%Turnover RatioLossP/E (Static)9.47MShares5.250052wk High-1.36P/B15.78MFloat Cap1.490052wk Low--Dividend TTM4.79MShs Float143.4487Historical High--Div YieldTTM27.54%Amplitude1.4900Historical Low2.9630Avg Price1Lot Size
Trinity Biotech Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.84%14.7M | -9.10%56.83M | -14.61%13.43M | -6.54%14.68M | -9.85%13.9M | -5.40%14.83M | -22.96%62.52M | 104.02%15.73M | -28.63%15.7M | -40.35%15.42M |
| Operating revenue | -0.84%14.7M | -9.10%56.83M | -14.61%13.43M | -6.54%14.68M | -9.85%13.9M | -5.40%14.83M | -22.96%62.52M | 104.02%15.73M | -28.63%15.7M | -40.35%15.42M |
| Cost of revenue | -0.80%9.18M | -17.39%37.38M | -14.39%8.86M | -32.38%10.4M | -9.83%8.87M | -4.51%9.26M | -5.12%45.25M | 103.20%10.35M | 17.33%15.38M | -33.62%9.84M |
| Gross profit | -0.92%5.52M | 12.64%19.45M | -15.03%4.57M | 1,200.91%4.28M | -9.87%5.03M | -6.84%5.57M | -48.38%17.27M | 105.62%5.38M | -96.30%329K | -49.39%5.58M |
| Operating expense | -9.79%8.56M | 14.96%35.39M | -23.34%8.06M | 42.26%8.78M | 31.18%9.07M | 31.87%9.49M | 14.03%30.79M | 26.71%10.51M | 0.65%6.17M | 45.79%6.91M |
| Selling and administrative expenses | -13.08%7.5M | 15.45%31.15M | -28.30%6.94M | 49.15%7.68M | 33.33%7.91M | 38.47%8.63M | 19.91%26.98M | 184.39%9.67M | -15.74%5.15M | -10.04%5.93M |
| Research and development costs | 26.63%1.09M | 5.82%4.38M | -4.20%1.12M | 14.27%1.17M | 25.30%1.23M | -10.88%860K | -7.98%4.14M | 23.91%1.17M | -3.76%1.02M | -6.82%984K |
| Other operating expenses | ---29K | 58.56%-138K | 100.91%3K | -6,900.00%-70K | -7,000.00%-71K | ---- | ---333K | ---331K | 99.90%-1K | 99.97%-1K |
| Operating profit | 22.40%-3.04M | -17.92%-15.94M | 32.03%-3.49M | 22.98%-4.5M | -203.31%-4.04M | -222.29%-3.92M | -309.48%-13.52M | 9.62%-5.13M | -311.09%-5.84M | -121.17%-1.33M |
| Net non-operating interest income expense | 91.28%-209K | 33.02%-9.88M | -123.31%-1.73M | -7.71%-2M | 54.69%-3.76M | 80.03%-2.4M | -151.67%-14.75M | 348.69%7.41M | -58.95%-1.86M | -2,298.84%-8.3M |
| Non-operating interest income | -64.29%55K | --0 | -83.89%-605K | 18.24%389K | --62K | -29.36%154K | --0 | 72.81%-329K | 69.59%329K | --0 |
| Non-operating interest expense | -89.65%264K | -12.00%10.15M | 112.66%1.39M | 9.29%2.39M | -53.94%3.82M | -79.13%2.55M | 111.71%11.53M | -911.56%-10.96M | 60.47%2.18M | 508.50%8.3M |
| Total other finance cost | ---- | -108.26%-266K | ---- | ---- | ---- | ---- | 670.57%3.22M | ---- | ---- | ---- |
| Other net income (expense) | 28.41%-11.1M | 97.74%-287K | -1,983.82%-10.82M | -516.34%-15.51M | -457.52%-12.7M | -2.29M | 91.45%-519K | |||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---9.68M | ---- | ---- | ---- |
| Special income (charges) | ---- | -90.41%-11.11M | 90.41%-290K | --0 | -1,983.82%-10.82M | ---- | -131.43%-5.83M | -185.23%-3.02M | ---2.29M | 91.45%-519K |
| -Less:Impairment of capital assets | ---- | 79.30%9.61M | ---- | ---- | ---- | ---- | -15.78%5.36M | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | 99.84%-7K | ---- | ---- | ---- |
| -Write off | ---- | 211.20%1.5M | -300.47%-9.32M | --0 | 1,983.82%10.82M | ---- | -17.32%482K | 57.59%-2.33M | --2.29M | -91.45%519K |
| Other non- operating income (expenses) | ---- | 0.00%3K | ---- | ---- | ---- | ---- | -25.00%3K | ---- | ---- | ---- |
| Income before tax | 48.54%-3.25M | 15.65%-36.93M | 47.23%-5.5M | 34.93%-6.5M | -83.38%-18.61M | 52.22%-6.32M | -2,175.47%-43.78M | -104.25%-10.43M | -723.74%-9.99M | -7,829.69%-10.15M |
| Income tax | 709.09%67K | 69.59%-59K | 76.92%-3K | 11,000.00%222K | -734.38%-267K | 92.67%-11K | -162.16%-194K | 98.80%-13K | -99.20%2K | -104.89%-32K |
| Net income | 42.90%-3.32M | 41.43%-24.02M | 45.42%-5.5M | 24.86%-6.72M | 38.31%-5.99M | 52.69%-5.81M | -4,786.74%-41.01M | -696.76%-10.08M | -777.14%-8.95M | -1,139.59%-9.71M |
| Net income continuous Operations | 47.39%-3.32M | 15.41%-36.87M | 47.20%-5.5M | 32.72%-6.72M | -81.32%-18.35M | 51.76%-6.31M | -2,256.00%-43.59M | -159.07%-10.41M | -839.85%-9.99M | -1,192.21%-10.12M |
| Net income discontinuous operations | --0 | 398.64%12.85M | -100.90%-3K | -100.10%-1K | 2,899.51%12.36M | -37.29%496K | -5.43%2.58M | -87.91%333K | 3,696.55%1.04M | --412K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 42.90%-3.32M | 41.43%-24.02M | 45.42%-5.5M | 24.86%-6.72M | 38.31%-5.99M | 52.69%-5.81M | -4,786.74%-41.01M | -696.76%-10.08M | -777.14%-8.95M | -1,139.59%-9.71M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 42.90%-3.32M | 41.43%-24.02M | 45.42%-5.5M | 24.86%-6.72M | 38.31%-5.99M | 52.69%-5.81M | -4,786.74%-41.01M | -696.76%-10.08M | -777.14%-8.95M | -1,139.59%-9.71M |
| Basic earnings per share | 50.85%-7.48 | 46.67%-3.2 | -983.77%-14.36 | 25.53%-0.875 | 45.07%-0.78 | -508.80%-15.22 | -3,100.00%-6 | -341.67%-1.325 | -473.02%-1.175 | -655.32%-1.42 |
| Diluted earnings per share | 50.85%-7.48 | 46.67%-3.2 | -983.77%-14.36 | 25.53%-0.875 | 45.07%-0.78 | -508.80%-15.22 | -3,100.00%-6 | -341.67%-1.325 | -485.25%-1.175 | -655.32%-1.42 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
